Read + Share
Wang M, Jurczak W, Trneny M, Belada D, et al. Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final
analysis of the phase 3 SYMPATICO study. Br J Haematol 2026 Jul 12. doi: 10.1111/bjh.70620.
PMID: 42438219
|
 |
|
Wang M, Jurczak W, Trneny M, Belada D, et al. Ibrutinib plus venetoclax for relapsed/refractory mantle cell lymphoma: Final
analysis of the phase 3 SYMPATICO study. Br J Haematol 2026 Jul 12. doi: 10.1111/bjh.70620.
PMID: 42438219
|
|
|
|